ProCE Banner Activity

Key HIV Studies Influencing My Practice Following IDWeek 2021—Rapid Recap by Eric S. Daar, MD

Conference Coverage
Multimedia
Hear unique insights from expert faculty as he presents updates and new HIV data from IDWeek 2021, including 2-drug ART, metabolic outcomes, investigational agents, and survey data of the U=U educational campaign.

Released: October 21, 2021

Expiration: October 20, 2022

No longer available for credit.

Share

Faculty

Eric S. Daar

Eric S. Daar, MD

Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare

Faculty Disclosure

Primary Author

Eric S. Daar, MD

Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Eric S. Daar, has disclosed that he has received consulting fees from Gilead Sciences and Merck and funds for research support from Gilead Sciences, Merck, and ViiV.